BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
5/26/2021 8:55:40 AM | Browse: 715 | Download: 1736
 |
Received |
|
2021-01-16 00:47 |
|
Peer-Review Started |
|
2021-01-16 00:49 |
|
First Decision by Editorial Office Director |
|
2021-02-14 00:18 |
|
Return for Revision |
|
2021-02-14 00:18 |
|
Revised |
|
2021-02-27 16:24 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2021-04-20 13:10 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2021-04-22 14:37 |
|
Articles in Press |
|
2021-04-22 14:37 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2021-05-07 14:53 |
|
Publish the Manuscript Online |
|
2021-05-26 08:55 |
| ISSN |
1948-0210 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Research & Experimental Medicine |
| Manuscript Type |
Minireviews |
| Article Title |
Different kinds of stem cells in the development of SARS-CoV-2 treatments
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Monica Maribel Mata-Miranda, Miguel Sanchez-Brito and Gustavo Jesus Vazquez-Zapien |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Gustavo Jesus Vazquez-Zapien, MD, PhD, Doctor, Doctor, Professor, Embryology Laboratory, Escuela Militar de Medicina, Cerrada de Palomas S/N, Mexico 11200, Mexico. gus1202@hotmail.com |
| Key Words |
COVID-19; SARS-CoV-2; Stem cells; Exosomes; Pluripotent stem cells; Mesenchymal stem cells; Artificial stem cells |
| Core Tip |
The use of stem cells (SCs) to address the coronavirus disease 2019 (COVID-19) pandemic has been widely studied in various fields; for example, human embryonic SCs and human induced pluripotent SCs have been used to generate functional human cells, tissues, and organoids that are used for modeling COVID-19 and discovering drugs. Mesenchymal SCs and their exosomes have been used in clinical trials to control the severe acute respiratory syndrome coronavirus 2 immune response, showing absorption of pulmonary lesions and clinical improvement. |
| Publish Date |
2021-05-26 08:55 |
| Citation |
Mata-Miranda MM, Sanchez-Brito M, Vazquez-Zapien GJ. Different kinds of stem cells in the development of SARS-CoV-2 treatments. World J Stem Cells 2021; 13(5): 439-451 |
| URL |
https://www.wjgnet.com/1948-0210/full/v13/i5/439.htm |
| DOI |
https://dx.doi.org/10.4252/wjsc.v13.i5.439 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
